Large cell/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors. - Wikidata - wikimedia - TriplyDB

Large cell/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors.

Large cell/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors.

http://www.wikidata.org/entity/Q54709976

about

Advancements in the treatment of pediatric acute leukemia and brain tumor - continuous efforts for 100% cure Cerebellum development and medulloblastoma c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients.Clinico-pathological description of three paediatric medulloblastoma cases with MLL2/3 gene mutations.Analysis of different medulloblastoma histotypes by two-dimensional gel and MALDI-TOF.Childhood brain tumors: epidemiology, current management and future directions.Histology predicts a favorable outcome in young children with desmoplastic medulloblastoma: a report from the children's oncology group.Molecular subgroups of medulloblastoma.Large cell anaplastic medulloblastoma metastatic to the scalp: tumor and derived stem-like cells features MB3W1 is an orthotopic xenograft model for anaplastic medulloblastoma displaying cancer stem cell- and Group 3-properties Isochromosome 17q, MYC amplification and large cell/anaplastic phenotype in a case of medullomyoblastoma with extracranial metastases.Clinical neuropathology practice guide 3-2013: levels of evidence and clinical utility of prognostic and predictive candidate brain tumor biomarkers Epigenetic silencing of miRNA-9 is associated with HES1 oncogenic activity and poor prognosis of medulloblastoma.Treatment of posterior fossa tumors in children.Molecular diagnostics of CNS embryonal tumors.Review: personalized mice: modelling the molecular heterogeneity of medulloblastoma.Pediatric neuro-oncology: current status and future directions.HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment.Identification of c-myc-dependent proteins in the medulloblastoma cell line D425Med.Prognostic value of the TP53 Arg72Pro single-nucleotide polymorphism and susceptibility to medulloblastoma in a cohort of Brazilian patients.Impact of tumor location and fourth ventricle infiltration in medulloblastoma.Panobinostat, a histone deacetylase inhibitor, suppresses leptomeningeal seeding in a medulloblastoma animal model.Treatment of pediatric average-risk medulloblastoma using craniospinal irradiation less than 2500 cGy and chemotherapy: single center experience in Korea.Impact of molecular biology studies on the understanding of brain tumors in childhood.Histological variants of medulloblastoma are the most powerful clinical prognostic indicators.Aggressive large cell medulloblastoma extending to the extracranial region in brain-dead state.

P2860

Q27027799-E041BA2C-19A2-4EAB-B5A5-70A4F107652F Q28304753-FC0AB7D4-AD9A-4064-80E9-1EB036C94B6B Q33821504-03C00589-0CA4-4001-82FD-49A36A097C0E Q33825507-FB13AF49-7DEF-4A17-84DC-9929D8D94C42 Q33946693-D7C1184B-C441-46AB-A307-4E3287FDFA2C Q33970971-D374EC41-B4D9-44E0-8FDC-D7639999B8BF Q35058988-6899821C-678D-4110-BE9B-BFA024EBAE35 Q35101347-F541584A-50CC-4942-BC11-B719871D6825 Q35150189-EF68488D-B94D-401C-B771-2FF322607C7D Q35925281-B70FBAC1-EF08-4C46-A574-AB9FA209049B Q36083984-1864515C-BA70-4767-B6CC-3A9458B1DAE9 Q36873451-D0DDCA52-1AB7-441B-825E-CDE812178FDC Q37559030-39627F33-204F-4134-BEE6-0E4288B2C769 Q37724213-0026010A-6D75-4E94-AA7A-5CA0CAE7620B Q37794829-4114E9D2-D2D9-484C-B3D9-77F6436111D1 Q37954412-578DCB3A-1F86-4FDA-A461-CE5C16BC375D Q38035070-672111C3-32C1-4440-A5FC-A33BDA2225FC Q39262034-4169B552-F03D-4340-B5EF-247ACC64DEF9 Q39525739-10A98639-E754-4928-AF4B-7817C032B798 Q39570440-53CD94C8-1897-486F-ACF6-026EB357A4F4 Q39828699-DECC2753-6705-4EFE-82FB-AD1885A992AD Q41344917-A215C940-B634-4412-A821-2D53BF967A8A Q47363064-41962957-0A8D-4D2D-873C-06FA95F83C8E Q48716816-15C8D401-2C4A-4E2B-8E85-F00E52E54BBA Q55462103-0E312653-4AFB-4820-8FF7-16F014EDAE43 Q55463131-061F8755-F9B1-44ED-86FB-095442CE5302

P2860

Large cell/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors.

http://www.wikidata.org/entity/Q54709976

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Large cell/anaplastic medullob ...... al, and clinical risk factors.

@en

Large cell/anaplastic medullob ...... al, and clinical risk factors.

@nl

type

label

Large cell/anaplastic medullob ...... al, and clinical risk factors.

@en

Large cell/anaplastic medullob ...... al, and clinical risk factors.

@nl

prefLabel

Large cell/anaplastic medullob ...... al, and clinical risk factors.

@en

Large cell/anaplastic medullob ...... al, and clinical risk factors.

@nl

P1433

Q54709976-D5795B8A-ED80-4729-8757-6117F03E00C7

P1476

Q54709976-E45906BA-070C-4085-8418-11020A62F0BA

P2093

Q54709976-2728EB35-EA60-4D36-B50E-7AEBD1433F5B

Q54709976-34CB4A04-B9BD-4078-9526-5770961B9856

Q54709976-80941A85-B4FC-4AE5-A190-43D814D72EDE

Q54709976-91E77D1D-7B8F-4E73-AAFA-9FBAE2A6BCD0

Q54709976-97439D95-0B44-4F2F-A01C-39E7251C2B2D

Q54709976-BB74BF02-9CD4-4E61-85E3-74D72A66BCBE

Q54709976-D4E0F5C0-644E-442F-AF1E-7828AEE70A43

P2860

Q54709976-1BA7656E-6E9A-4C11-878B-E4ED98C39A05

Q54709976-4CF65255-F3B3-48DF-86E1-A1A43ECE89FB

Q54709976-5D908A24-7792-4433-BC10-9C02002E9995

Q54709976-6892D906-E8A2-4263-A98E-FF66B0BB10BA

Q54709976-C9D660CC-C182-46E1-9A79-03949B569F98

P304

Q54709976-2B1131CC-C3D9-489A-A75F-D6D874DF1FA3

P31

Q54709976-FC8ACBCD-6190-491C-BEE9-EDC29D17ED2D

P356

Q54709976-3DBA4F9F-C575-4068-80BA-763A5EAE2917

P433

Q54709976-D5B46AE8-FB01-4EAD-9C5F-2C5AF1EFDD49

P478

Q54709976-94884D85-F76C-421B-9CB0-D1CB3D5E33AB

P577

Q54709976-D4E5B719-B97F-4077-B589-4469113888AE

P5875

Q54709976-076BCE0C-4051-4B93-A7DB-523E3255E892

P698

Q54709976-04C98678-5616-48B9-A1D5-F316C66A6C5A

P921

Q54709976-2904BD19-B002-4581-B6DC-245C976E8DFB

P356

P1433

Pediatric Blood & Cancer

P1476

Large cell/anaplastic medullob ...... al, and clinical risk factors.

@en

P2093

André Oscar von Bueren

http://www.w3.org/2001/XMLSchema#string

Katja von Hoff

http://www.w3.org/2001/XMLSchema#string

Michael Andreas Grotzer

http://www.w3.org/2001/XMLSchema#string

Nicolas Ulrich Gerber

http://www.w3.org/2001/XMLSchema#string

Stefan Rutkowski

http://www.w3.org/2001/XMLSchema#string

Torsten Pietsch

http://www.w3.org/2001/XMLSchema#string

Wolfgang Hartmann

http://www.w3.org/2001/XMLSchema#string

P2860

Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia.

Morphophenotypic variation predicts clinical behavior in childhood non-desmoplastic medulloblastomas.

An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas.

Conformal radiotherapy, reduced boost volume, hyperfractionated radiotherapy, and online quality control in standard-risk medulloblastoma without chemotherapy: results of the French M-SFOP 98 protocol.

"Large cell/anaplastic" medulloblastomas: a Pediatric Oncology Group Study.

P304

369-376

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PBC.22339

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

54

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

227702454

http://www.w3.org/2001/XMLSchema#string

P698

19908297

http://www.w3.org/2001/XMLSchema#string

P921

medulloblastoma